These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 22953991

  • 1. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
    Yamazaki CA, Padovani RP, Biscolla RP, Ikejiri ES, Marchetti RR, Castiglioni ML, Matsumura LK, Maciel RM, Furlanetto RP.
    Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
    [Abstract] [Full Text] [Related]

  • 2. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF, Oei HY, Hennemann G, Krenning EP.
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [Abstract] [Full Text] [Related]

  • 3. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL, Rodríguez Rodríguez JR, Borrego Dorado I, Navarro González E, Tirado Hospital JL, Vázquez Albertino R.
    Rev Esp Med Nucl; 2007 Jun; 26(3):138-45. PubMed ID: 17524307
    [Abstract] [Full Text] [Related]

  • 4. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM, Kim ES, Ryu JS, Hong SJ, Kim WB, Shong YK.
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [Abstract] [Full Text] [Related]

  • 5. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M.
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [Abstract] [Full Text] [Related]

  • 6. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW, Mineiro Filho AF, Lacerda RX, dos Santos DA, Calsolari MR.
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic 123I Whole Body Scan Prior to Ablation of Thyroid Remnant in Patients With Papillary Thyroid Cancer: Implications for Clinical Management.
    Song H, Mosci C, Akatsu H, Basina M, Dosiou C, Iagaru A.
    Clin Nucl Med; 2018 Oct; 43(10):705-709. PubMed ID: 30153149
    [Abstract] [Full Text] [Related]

  • 8. [Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi].
    Kukulska A, Krajewska J, Roskosz J, Handkiewicz-Junak D, Jarzab M, Paliczka E, Puch Z, Wygoda Z, Gubała E, Jarzab B.
    Endokrynol Pol; 2006 Oct; 57(4):374-9. PubMed ID: 17006839
    [Abstract] [Full Text] [Related]

  • 9. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, Pasquini C, Piazza F, Caciagli M, Mariani G.
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [Abstract] [Full Text] [Related]

  • 10. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z, Turgut B, Kilicli F, Altuntas EE, Yucel B.
    Asian Pac J Cancer Prev; 2014 Sep; 15(6):2523-7. PubMed ID: 24761858
    [Abstract] [Full Text] [Related]

  • 11. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
    Küçük ON, Gültekin SS, Aras G, Ibiş E.
    Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N, Cavaliere H, Tomimori E, Knobel M, Medeiros-Neto G.
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium.
    Barbaro D, Grosso M, Boni G, Lapi P, Pasquini C, Orsini P, Turco A, Meucci G, Marzola MC, Berti P, Miccoli P, Mariani G, Rubello D.
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):242-9. PubMed ID: 19760415
    [Abstract] [Full Text] [Related]

  • 14. Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancer.
    Tresoldi AS, Sburlati LF, Rodari M, Schinkelshoek MS, Perrino M, De Leo S, Montefusco L, Colombo P, Arosio M, Lania AGA, Fugazzola L, Chiti A.
    J Endocrinol Invest; 2014 Aug; 37(8):709-714. PubMed ID: 24844565
    [Abstract] [Full Text] [Related]

  • 15. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW, Calsolari MR.
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [Abstract] [Full Text] [Related]

  • 16. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
    Roelants V, Nayer PD, Bouckaert A, Beckers C.
    Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
    [Abstract] [Full Text] [Related]

  • 17. Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer.
    Caglar M, Bozkurt FM, Akca CK, Vargol SE, Bayraktar M, Ugur O, Karaağaoğlu E.
    Nucl Med Commun; 2012 Mar; 33(3):268-74. PubMed ID: 22205241
    [Abstract] [Full Text] [Related]

  • 18. Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma.
    Pacini F, Molinaro E, Lippi F, Castagna MG, Agate L, Ceccarelli C, Taddei D, Elisei R, Capezzone M, Pinchera A.
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5686-90. PubMed ID: 11739420
    [Abstract] [Full Text] [Related]

  • 19. Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer.
    Torlontano M, Crocetti U, D'Aloiso L, Bonfitto N, Di Giorgio A, Modoni S, Valle G, Frusciante V, Bisceglia M, Filetti S, Schlumberger M, Trischitta V.
    Eur J Endocrinol; 2003 Jan; 148(1):19-24. PubMed ID: 12534353
    [Abstract] [Full Text] [Related]

  • 20. Endogenously labeled thyroid hormones (131I-T3/T4) in sera of patients with differentiated thyroid carcinoma.
    Lukinac L, Franceschi M, Nöthig-Hus D, Lechpammer S, Tomasić J, Vranesić B, Pape E, Kusić Z.
    Thyroid; 1996 Jun; 6(3):201-6. PubMed ID: 8837327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.